The Pfizer Australia CVL research Grants were established in 1999 to support clinical research into cardiovascular disease or related therapeutic areas.
澳洲辉瑞心血管脂类(CVL)研究金建立于1999，用于资助心血管疾病或相关治疗领域的临床研究。
2
Speaking in London about his research, Prof Hwang warned people not to expect clinical applications of therapeutic cloning in the near future.
在伦敦就他的研究发表演讲时，黄教授警告人们，不要期望治疗性克隆不久就能应用于临床。
3
The method is simple and sensitive enough to be used for clinical pharmacological research and therapeutic drug monitoring.